rs548804317

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2

The NM_004260.4(RECQL4):​c.2569_2574delTGCACC​(p.Cys857_Thr858del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,574,460 control chromosomes in the GnomAD database, including 41 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. C857C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0024 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0015 ( 38 hom. )

Consequence

RECQL4
NM_004260.4 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.833
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_004260.4.
BP6
Variant 8-144513027-TGGTGCA-T is Benign according to our data. Variant chr8-144513027-TGGTGCA-T is described in ClinVar as [Likely_benign]. Clinvar id is 135140.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144513027-TGGTGCA-T is described in Lovd as [Likely_benign]. Variant chr8-144513027-TGGTGCA-T is described in Lovd as [Likely_pathogenic].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0024 (365/152314) while in subpopulation AMR AF = 0.015 (229/15306). AF 95% confidence interval is 0.0134. There are 3 homozygotes in GnomAd4. There are 182 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RECQL4NM_004260.4 linkc.2569_2574delTGCACC p.Cys857_Thr858del conservative_inframe_deletion Exon 15 of 21 ENST00000617875.6 NP_004251.4 O94761

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RECQL4ENST00000617875.6 linkc.2569_2574delTGCACC p.Cys857_Thr858del conservative_inframe_deletion Exon 15 of 21 1 NM_004260.4 ENSP00000482313.2 O94761
RECQL4ENST00000621189.4 linkc.1498_1503delTGCACC p.Cys500_Thr501del conservative_inframe_deletion Exon 14 of 20 1 ENSP00000483145.1 A0A087X072
RECQL4ENST00000534626.6 linkc.739_744delTGCACC p.Cys247_Thr248del conservative_inframe_deletion Exon 6 of 8 5 ENSP00000477457.1 V9GZ64
ENSG00000265393ENST00000580385.1 linkn.271+205_271+210delTGCAGG intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.00239
AC:
364
AN:
152196
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0121
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00737
AC:
1382
AN:
187612
AF XY:
0.00575
show subpopulations
Gnomad AFR exome
AF:
0.000983
Gnomad AMR exome
AF:
0.0410
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0152
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000997
Gnomad OTH exome
AF:
0.00403
GnomAD4 exome
AF:
0.00149
AC:
2114
AN:
1422146
Hom.:
38
AF XY:
0.00136
AC XY:
958
AN XY:
703984
show subpopulations
Gnomad4 AFR exome
AF:
0.000614
AC:
20
AN:
32558
Gnomad4 AMR exome
AF:
0.0361
AC:
1386
AN:
38370
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
25434
Gnomad4 EAS exome
AF:
0.0124
AC:
462
AN:
37372
Gnomad4 SAS exome
AF:
0.000626
AC:
51
AN:
81492
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
49210
Gnomad4 NFE exome
AF:
0.000102
AC:
112
AN:
1093028
Gnomad4 Remaining exome
AF:
0.00141
AC:
83
AN:
58958
Heterozygous variant carriers
0
121
242
363
484
605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00240
AC:
365
AN:
152314
Hom.:
3
Cov.:
34
AF XY:
0.00244
AC XY:
182
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00123
AC:
0.00122673
AN:
0.00122673
Gnomad4 AMR
AF:
0.0150
AC:
0.0149615
AN:
0.0149615
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.0122
AC:
0.0121575
AN:
0.0121575
Gnomad4 SAS
AF:
0.00228
AC:
0.00227838
AN:
0.00227838
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000735
AC:
0.0000735208
AN:
0.0000735208
Gnomad4 OTH
AF:
0.00284
AC:
0.00283554
AN:
0.00283554
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000293
Hom.:
0
Bravo
AF:
0.00503

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 12, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24728327) -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RECQL4: PM4, BS1, BS2 -

Rothmund-Thomson syndrome type 2 Benign:2
May 25, 2020
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as BENIGN. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0215 - In-frame insertion/deletion fully contained in a repetitive region that has low conservation (exon 15). (P) 0251 - Variant is heterozygous. (N) 0306 - Variant is present in gnomAD >=0.03 and <0.05 for a recessive condition (1402 heterozygotes, 30 homozygotes). (B) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0806 - Moderate previous evidence of neutrality in unrelated individuals. Two Benign reports (ClinVar). (B) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1Other:1
Dec 20, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Rapadilino syndrome Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Dec 17, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Baller-Gerold syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=178/22
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs548804317; hg19: chr8-145738410; COSMIC: COSV52879881; COSMIC: COSV52879881; API